Evidence map›Paper›PMID 38089660›Full record

ArticleACS materials Au2023

MXene-Integrated Silk Fibroin-Based Self-Assembly-Driven 3D-Printed Theragenerative Scaffolds for Remotely Photothermal Anti-Osteosarcoma Ablation and Bone Regeneration.

Hadice Kübra Pektas, Yan Demidov, Aslin Ahvan, Nahal Abie, Veronika S Georgieva, Shiyi Chen, Silvia Farè, Bent Brachvogel, Sanjay Mathur, Hajar Maleki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS materials Au, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. MXene Bioinks for 3D Bioprinting: Design and Translation.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Beyond graphene: the MXene era in bioprinting.Biomedical engineering online · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Hadice Kübra PektasDepartment of Chemistry, Institute of Inorganic Chemistry, University of Cologne, Cologne 50939, Germany.
Yan DemidovDepartment of Chemistry, Institute of Inorganic Chemistry, University of Cologne, Cologne 50939, Germany.
Aslin AhvanDepartment of Chemistry, Institute of Inorganic Chemistry, University of Cologne, Cologne 50939, Germany.
Nahal AbieDepartment of Chemistry, Institute of Inorganic Chemistry, University of Cologne, Cologne 50939, Germany.
Veronika S GeorgievaExperimental Neonatology, Department of Pediatrics and Adolescent Medicine, University of Cologne, Cologne 50939, Germany.
Shiyi ChenDepartment of Chemistry, Institute of Inorganic Chemistry, University of Cologne, Cologne 50939, Germany.
Silvia FarèDepartment of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Milano 20054, Italy.ORCID https://orcid.org/0000-0002-0303-1131
Bent BrachvogelExperimental Neonatology, Department of Pediatrics and Adolescent Medicine, University of Cologne, Cologne 50939, Germany.
Sanjay MathurDepartment of Chemistry, Institute of Inorganic Chemistry, University of Cologne, Cologne 50939, Germany.ORCID https://orcid.org/0000-0003-2765-2693
Hajar MalekiDepartment of Chemistry, Institute of Inorganic Chemistry, University of Cologne, Cologne 50939, Germany.
University of Cologne · DEPolitecnico di Milano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aiming to address the bone regeneration and cancer therapy functionalities in one single material, in this study, we developed a dual-functional theragenerative three-dimensional (3D) aerogel-based composite scaffold from hybridization of photo-cross-linked silk fibroin (SF) biopolymer with MXene (Ti

Identifiers

PMID38089660
PMCPMC10636780
OpenAlexW4386537387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.